Literature DB >> 6023435

Cyclophosphamide inhibition of experimental allergic encephalomyelitis in Wistar rats.

P Y Paterson, M A Hanson, E W Gerner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6023435     DOI: 10.3181/00379727-124-31888

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

1.  Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.

Authors:  L Korcáková; M Titlbach; K Nouza
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

2.  The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

Authors:  M C Berenbaum; W A Cope; J A Double
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  [Immunoactivation with ethylnitrosourea].

Authors:  M Kupfer; G Kupfer; U Berger
Journal:  Naturwissenschaften       Date:  1969-04

4.  [Effect of heterologous antilymphocyte serum on experimental allergic encephalomyelitis].

Authors:  W Land; E Frick; R Roscher; W Brendel; A Baethmann
Journal:  Klin Wochenschr       Date:  1969-06-15

5.  [Effect of antilymphocyte globulin in experimental allergic encephalomyelitis of guinea pigs].

Authors:  H Warnatz; F Scheiffarth; A Scheder
Journal:  Klin Wochenschr       Date:  1970-06-01

6.  Lymphocyte deactivation by (potential immunosuppressant) alkylating metabolites of cyclophosphamide.

Authors:  M W Whitehouse; F W Beck; M M Dröge; R F Struck
Journal:  Agents Actions       Date:  1974-04

7.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.